264 studies found for:
"Emtricitabine"[TREATMENT] AND HIV [CONDITION]
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 21 |
Completed
Has Results |
Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV
|
||||
| 22 | Recruiting |
Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in Men Who Have Sex With Men and in At-Risk Women
|
||||
| 23 | Completed |
Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients
|
||||
| 24 | Active, not recruiting |
Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)
|
||||
| 25 | Unknown † |
Raltegravir Switch for Toxicity or Adverse Events
|
||||
| 26 | Completed |
Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl
|
||||
| 27 | Completed |
Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)
|
||||
| 28 | Unknown † |
Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV
|
||||
| 29 | Completed |
Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection
|
||||
| 30 | Completed |
Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women
|
||||
| 31 | Unknown † |
Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis
|
||||
| 32 | Completed |
Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)
|
||||
| 33 | Completed |
Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants
|
||||
| 34 | Completed |
Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection
|
||||
| 35 | Active, not recruiting |
Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients
|
||||
| 36 |
Completed
Has Results |
Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects
|
||||
| 37 | Active, not recruiting |
Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects
|
||||
| 38 | Active, not recruiting |
Safety and Efficacy of GS-9350-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
|
||||
| 39 |
Completed
Has Results |
FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment
|
||||
| 40 |
Completed
Has Results |
Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection
|
† Indicates status has not been verified in more than two years

